By Laura Lovett on August 30, 2022

Serious mental illnesses (SMIs) are extremely costly and can lead to negative health outcomes, a fact that makes this corner of the behavioral health world ripe for innovation. Specializing in SMI treatment, however, comes with a number of high-stakes challenges.

SMIs – conditions such as schizophrenia, severe bipolar disorder and major depression – impact roughly 5% of the U.S. population. Additionally, the economic cost of SMI is more than $300 billion each year, according to SMI Advisor.

Read the full piece via Behavioral Health Business >>